ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $73,364,000 | -38.6% | 426,285 | -55.2% | 0.09% | -37.1% |
| Q2 2021 | $119,480,000 | -9.9% | 952,110 | -2.7% | 0.14% | -14.9% |
| Q1 2021 | $132,668,000 | -13.1% | 978,306 | -18.1% | 0.17% | -9.7% |
| Q4 2020 | $152,755,000 | +15.0% | 1,193,957 | +1.2% | 0.19% | -1.1% |
| Q3 2020 | $132,804,000 | +81.4% | 1,180,167 | +53.6% | 0.19% | +60.7% |
| Q2 2020 | $73,200,000 | +59.9% | 768,345 | +50.8% | 0.12% | +19.4% |
| Q1 2020 | $45,784,000 | +9.1% | 509,450 | -35.7% | 0.10% | +34.2% |
| Q4 2019 | $41,978,000 | +41.9% | 791,739 | +5.8% | 0.07% | +30.4% |
| Q3 2019 | $29,579,000 | +10.0% | 748,646 | +14.3% | 0.06% | +12.0% |
| Q2 2019 | $26,896,000 | -2.4% | 654,718 | +10.6% | 0.05% | -7.4% |
| Q1 2019 | $27,566,000 | +31.0% | 591,918 | +22.5% | 0.05% | +14.9% |
| Q4 2018 | $21,042,000 | -28.2% | 483,167 | -5.7% | 0.05% | -16.1% |
| Q3 2018 | $29,325,000 | +50.3% | 512,411 | +27.4% | 0.06% | +43.6% |
| Q2 2018 | $19,512,000 | +41.7% | 402,148 | +14.2% | 0.04% | +39.3% |
| Q1 2018 | $13,774,000 | -12.9% | 352,286 | -5.4% | 0.03% | -6.7% |
| Q4 2017 | $15,806,000 | +32.4% | 372,438 | +16.4% | 0.03% | +36.4% |
| Q3 2017 | $11,938,000 | – | 319,871 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |